|
Study on reducing seasonal asthma attacks in children
HNGnews.com A previous ICAC study found that adding year-round treatment with omalizumab (brand name Xolair) to guidelines-based asthma care decreased the number of seasonal episodes of worsening asthma, with the most striking effects observed during the fall. |
View full post on asthma – Google News